JP2021156577A - 閉塞性肺疾患バイオマーカー - Google Patents

閉塞性肺疾患バイオマーカー Download PDF

Info

Publication number
JP2021156577A
JP2021156577A JP2018121888A JP2018121888A JP2021156577A JP 2021156577 A JP2021156577 A JP 2021156577A JP 2018121888 A JP2018121888 A JP 2018121888A JP 2018121888 A JP2018121888 A JP 2018121888A JP 2021156577 A JP2021156577 A JP 2021156577A
Authority
JP
Japan
Prior art keywords
protein
subunit
ribosomal
factor
ribosomal protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018121888A
Other languages
English (en)
Japanese (ja)
Inventor
吉人 武田
Yoshito Takeda
吉人 武田
淳 熊ノ郷
Atsushi Kumanosato
淳 熊ノ郷
宗到 玄山
Muneyoshi Kuroyama
宗到 玄山
太郎 木庭
Taro Kiba
太郎 木庭
幸嗣 植田
Yukitsugu Ueda
幸嗣 植田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japanese Foundation for Cancer Research
Osaka University NUC
Original Assignee
Japanese Foundation for Cancer Research
Osaka University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japanese Foundation for Cancer Research, Osaka University NUC filed Critical Japanese Foundation for Cancer Research
Priority to JP2018121888A priority Critical patent/JP2021156577A/ja
Priority to PCT/JP2019/025632 priority patent/WO2020004557A1/fr
Publication of JP2021156577A publication Critical patent/JP2021156577A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2018121888A 2018-06-27 2018-06-27 閉塞性肺疾患バイオマーカー Pending JP2021156577A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2018121888A JP2021156577A (ja) 2018-06-27 2018-06-27 閉塞性肺疾患バイオマーカー
PCT/JP2019/025632 WO2020004557A1 (fr) 2018-06-27 2019-06-27 Biomarqueurs de maladies pulmonaires obstructives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018121888A JP2021156577A (ja) 2018-06-27 2018-06-27 閉塞性肺疾患バイオマーカー

Publications (1)

Publication Number Publication Date
JP2021156577A true JP2021156577A (ja) 2021-10-07

Family

ID=68984543

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018121888A Pending JP2021156577A (ja) 2018-06-27 2018-06-27 閉塞性肺疾患バイオマーカー

Country Status (2)

Country Link
JP (1) JP2021156577A (fr)
WO (1) WO2020004557A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023153496A1 (fr) * 2022-02-10 2023-08-17 国立大学法人大阪大学 Biomarqueur de l'asthme éosinophilique ou bronchique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2585043A1 (fr) * 2004-10-22 2007-01-04 Medimmune, Inc. Anticorps d'affinite elevee contre la hmgb1 et procedes d'utilisation
CN102301002A (zh) * 2008-11-12 2011-12-28 卡里斯生命科学卢森堡控股有限责任公司 使用外来体来确定表现型的方法和系统
US20160033516A1 (en) * 2014-07-31 2016-02-04 Salk Institute For Biological Studies Use of polyclonal and monoclonal antibodies specific for 3-phosphohistidine
CN114965989A (zh) * 2015-02-09 2022-08-30 Dna吉诺特克股份有限公司 用于采集相关应用、分析和诊断的样本的设备、溶液和方法

Also Published As

Publication number Publication date
WO2020004557A1 (fr) 2020-01-02

Similar Documents

Publication Publication Date Title
EP3082840B1 (fr) Méthodes et dosages biologiques se rapportant à des cellules tumorales circulantes
Verhoeckx et al. A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line
EP3464597B1 (fr) Méthode de sélection de sondes oligonucléotidiques et utilisations de celles-ci
WO2012019300A1 (fr) Marqueurs biologiques d'un cancer endométrial et procédés pour les identifier et les utiliser
US20140235486A1 (en) Methods and Compositions for the Treatment and Diagnosis of Breast Cancer
WO2019173799A1 (fr) Sondes oligonucléotidiques et leurs utilisations
US20220170114A1 (en) Biomarkers of chronic lymphocytic leukemia and use thereof
JP2024010173A (ja) 尿路上皮がんを検査する方法
WO2020004557A1 (fr) Biomarqueurs de maladies pulmonaires obstructives
WO2018168769A1 (fr) Biomarqueur de fibrose tissulaire
WO2018145095A1 (fr) Procédés de prédiction de la réactivité d'un cancer à un agent immunothérapeutique et procédés de traitement du cancer
JP2010014689A (ja) プロテオミクス解析を用いたメラノーママーカーの同定
JP2018151276A (ja) 老化バイオマーカー
WO2018168779A1 (fr) Biomarqueur de la bronchopneumopathie chronique obstructive
JP2019158753A (ja) リンパ脈管筋腫症バイオマーカー
WO2020162441A1 (fr) Biomarqueur de maladie granulomateuse
WO2023153496A1 (fr) Biomarqueur de l'asthme éosinophilique ou bronchique
WO2023027186A1 (fr) Biomarqueur de fibrose pulmonaire
WO2018168768A1 (fr) Biomarqueur des maladies respiratoires obstructives
WO2022085687A1 (fr) Agent de prévention ou de traitement de maladies des voies respiratoires, procédé de détection, agent de détection, procédé de criblage de principe actif d'agent de prévention ou de traitement, et procédé d'évaluation d'inductibilité ou de risques d'aggravation
JP2023000812A (ja) 悪性胸膜中皮腫バイオマーカー
EP3133400B1 (fr) Utilisation de protéines associées à la fécondité masculine ak6 et gpx5 ou de leur combinaison
JP5229214B2 (ja) 診断のための生体分子
US20240192217A1 (en) Systems and methods for barrett's esophagus pathogenesis and esophageal adenocarcinoma progression revealing markers
AU2021275137A1 (en) Systems and methods for barrett's esophagus pathogenesis and esophageal adenocarcinoma progression revealing markers